Abstract
Pharmacologic treatment is an important component of the treatment of Complex Regional Pain Syndrome (CRPS). The medication quantification scale III (MQS III) is a validated measure to quantify the detriment (risk) of a patient’s medication regimen developed from a survey of pain medicine physicians. This retrospective study investigated whether treatment of CRPS in a comprehensive interdisciplinary pain management program would result in reduction in medication regimen detriment score as measured by the MQS III.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
